|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000135374 |
Summary for ELF5 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000135374 | Gene symbol | ELF5 |
| Gene name | E74 like ETS transcription factor 5 | |
| HGNC | 3320 | |
| Entrez ID | 2001 | |
| Gene type | protein_coding | |
| Synonyms | ELF5| | |
| UniProtAcc | Q9UKW6 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ELF5 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ELF5 | 2.28e+03 | -4.21e+00 | 7.62e-01 | -5.53e+00 | 3.29e-08 | 4.35e-06 | BRCA |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ELF5 | 4.88e+02 | -1.06e+00 | 3.70e-01 | -2.85e+00 | 4.31e-03 | 8.21e-03 | LUAD |
| ELF5 | 2.72e+02 | -2.79e+00 | 4.75e-01 | -5.87e+00 | 4.34e-09 | 2.32e-08 | HNSC |
| ELF5 | 4.49e+02 | -1.38e+00 | 3.16e-01 | -4.37e+00 | 1.25e-05 | 2.29e-05 | LUSC |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ELF5 | 3.27e+02 | -5.66e+00 | 9.11e-01 | -6.21e+00 | 5.20e-10 | 2.50e-08 | KIRP |
| ELF5 | 2.56e+03 | -1.16e+00 | 2.55e-01 | -4.55e+00 | 5.45e-06 | 9.13e-06 | BRCA |
Top |
Sex-biased somatic mutation for ELF5 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ELF5 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg19656820 | chr11:34513538 | CGI:chr11:34438618-34439310 | promoter,gene body | 6.78e-01 | 8.41e-01 | -2.47e+00 | 1.37e-02 | 3.01e-02 | -1.63e-01 |
| BRCA | cg22932313 | chr11:34513642 | CGI:chr11:34438618-34439310 | promoter,gene body | 6.82e-01 | 8.77e-01 | -2.60e+00 | 9.30e-03 | 2.60e-02 | -1.95e-01 |
| BRCA | cg11875459 | chr11:34513238 | CGI:chr11:34438618-34439310 | promoter,gene body | 7.89e-01 | 9.36e-01 | -2.88e+00 | 4.03e-03 | 1.87e-02 | -1.47e-01 |
| BRCA | cg24253136 | chr11:34513593 | CGI:chr11:34438618-34439310 | promoter,gene body | 6.70e-01 | 8.26e-01 | -2.40e+00 | 1.65e-02 | 3.24e-02 | -1.57e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg05390144 | chr11:34511917 | CGI:chr11:34438618-34439310 | promoter,gene body | 8.22e-01 | 6.12e-01 | 5.58e+00 | 2.43e-08 | 5.12e-07 | 2.10e-01 |
| THCA | cg12728032 | chr11:34513810 | CGI:chr11:34438618-34439310 | promoter | 6.24e-01 | 4.71e-01 | 4.51e+00 | 6.43e-06 | 9.20e-05 | 1.53e-01 |
| THCA | cg26129339 | chr11:34513869 | CGI:chr11:34438618-34439310 | promoter | 7.82e-01 | 6.39e-01 | 4.54e+00 | 5.53e-06 | 8.30e-05 | 1.43e-01 |
| HNSC | cg04504043 | chr11:34512933 | CGI:chr11:34438618-34439310 | promoter,gene body | 5.24e-01 | 6.82e-01 | -3.78e+00 | 1.55e-04 | 3.74e-04 | -1.58e-01 |
| LUSC | cg05390144 | chr11:34511917 | CGI:chr11:34438618-34439310 | promoter,gene body | 8.50e-01 | 6.85e-01 | 3.92e+00 | 8.72e-05 | 6.61e-04 | 1.65e-01 |
| LUSC | cg04504043 | chr11:34512933 | CGI:chr11:34438618-34439310 | promoter,gene body | 5.30e-01 | 6.47e-01 | -2.62e+00 | 8.82e-03 | 1.26e-02 | -1.17e-01 |
| BLCA | cg22932313 | chr11:34513642 | CGI:chr11:34438618-34439310 | promoter,gene body | 4.51e-01 | 6.86e-01 | -2.86e+00 | 4.30e-03 | 7.21e-03 | -2.35e-01 |
| BLCA | cg11875459 | chr11:34513238 | CGI:chr11:34438618-34439310 | promoter,gene body | 5.43e-01 | 8.46e-01 | -3.62e+00 | 2.91e-04 | 8.78e-04 | -3.03e-01 |
| BLCA | cg11343506 | chr11:34514021 | CGI:chr11:34438618-34439310 | promoter | 4.37e-01 | 6.92e-01 | -2.72e+00 | 6.58e-03 | 1.01e-02 | -2.55e-01 |
| BLCA | cg22731981 | chr11:34514032 | CGI:chr11:34438618-34439310 | promoter | 4.06e-01 | 5.92e-01 | -2.49e+00 | 1.26e-02 | 1.70e-02 | -1.85e-01 |
| LIHC | cg04504043 | chr11:34512933 | CGI:chr11:34438618-34439310 | promoter,gene body | 4.78e-01 | 6.00e-01 | -4.30e+00 | 1.72e-05 | 4.38e-05 | -1.22e-01 |
| KIRP | cg11870100 | chr11:34512995 | CGI:chr11:34438618-34439310 | promoter,gene body | 2.49e-01 | 3.69e-01 | -3.81e+00 | 1.37e-04 | 3.38e-04 | -1.20e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg22932313 | chr11:34513642 | CGI:chr11:34438618-34439310 | promoter,gene body | 6.82e-01 | 7.84e-01 | -2.94e+00 | 3.33e-03 | 4.05e-03 | -1.02e-01 |
| BRCA | cg04504043 | chr11:34512933 | CGI:chr11:34438618-34439310 | promoter,gene body | 6.59e-01 | 7.73e-01 | -4.78e+00 | 1.79e-06 | 3.24e-06 | -1.13e-01 |
| BRCA | cg24253136 | chr11:34513593 | CGI:chr11:34438618-34439310 | promoter,gene body | 6.70e-01 | 7.72e-01 | -3.21e+00 | 1.32e-03 | 1.70e-03 | -1.02e-01 |
| BRCA | cg01473816 | chr11:34513734 | CGI:chr11:34438618-34439310 | UTR,promoter,exon,gene body | 5.97e-01 | 7.62e-01 | -5.55e+00 | 2.81e-08 | 6.03e-08 | -1.65e-01 |
| BRCA | cg12728032 | chr11:34513810 | CGI:chr11:34438618-34439310 | promoter | 4.42e-01 | 5.69e-01 | -8.71e+00 | 3.09e-18 | 1.45e-17 | -1.28e-01 |
| BRCA | cg10987788 | chr11:34513830 | CGI:chr11:34438618-34439310 | promoter | 6.47e-01 | 8.11e-01 | -7.13e+00 | 9.93e-13 | 3.05e-12 | -1.64e-01 |
| BRCA | cg23311800 | chr11:34513849 | CGI:chr11:34438618-34439310 | promoter | 5.09e-01 | 6.83e-01 | -1.02e+01 | 1.87e-24 | 1.51e-23 | -1.74e-01 |
| BRCA | cg26129339 | chr11:34513869 | CGI:chr11:34438618-34439310 | promoter | 4.77e-01 | 6.44e-01 | -9.86e+00 | 5.94e-23 | 4.16e-22 | -1.67e-01 |
| BRCA | cg21017775 | chr11:34513934 | CGI:chr11:34438618-34439310 | promoter | 6.96e-01 | 8.29e-01 | -3.62e+00 | 2.98e-04 | 4.20e-04 | -1.34e-01 |
| BRCA | cg11343506 | chr11:34514021 | CGI:chr11:34438618-34439310 | promoter | 6.85e-01 | 8.14e-01 | -2.63e+00 | 8.60e-03 | 9.82e-03 | -1.29e-01 |
| KIRC | cg11875459 | chr11:34513238 | CGI:chr11:34438618-34439310 | promoter,gene body | 9.29e-01 | 7.64e-01 | 3.38e+00 | 7.22e-04 | 3.91e-03 | 1.66e-01 |
| HNSC | cg19656820 | chr11:34513538 | CGI:chr11:34438618-34439310 | promoter,gene body | 7.27e-01 | 5.76e-01 | 2.44e+00 | 1.46e-02 | 2.29e-02 | 1.51e-01 |
| HNSC | cg22932313 | chr11:34513642 | CGI:chr11:34438618-34439310 | promoter,gene body | 8.84e-01 | 6.50e-01 | 2.85e+00 | 4.37e-03 | 1.26e-02 | 2.34e-01 |
| HNSC | cg24253136 | chr11:34513593 | CGI:chr11:34438618-34439310 | promoter,gene body | 7.99e-01 | 6.69e-01 | 2.71e+00 | 6.64e-03 | 1.52e-02 | 1.30e-01 |
| HNSC | cg01473816 | chr11:34513734 | CGI:chr11:34438618-34439310 | UTR,promoter,exon,gene body | 7.92e-01 | 5.64e-01 | 2.90e+00 | 3.79e-03 | 1.19e-02 | 2.28e-01 |
| HNSC | cg12728032 | chr11:34513810 | CGI:chr11:34438618-34439310 | promoter | 5.59e-01 | 3.87e-01 | 2.65e+00 | 8.13e-03 | 1.67e-02 | 1.72e-01 |
| HNSC | cg10987788 | chr11:34513830 | CGI:chr11:34438618-34439310 | promoter | 8.25e-01 | 5.97e-01 | 2.91e+00 | 3.65e-03 | 1.18e-02 | 2.27e-01 |
| HNSC | cg23311800 | chr11:34513849 | CGI:chr11:34438618-34439310 | promoter | 6.54e-01 | 4.50e-01 | 2.79e+00 | 5.21e-03 | 1.36e-02 | 2.03e-01 |
| HNSC | cg26129339 | chr11:34513869 | CGI:chr11:34438618-34439310 | promoter | 5.23e-01 | 3.82e-01 | 2.47e+00 | 1.37e-02 | 2.21e-02 | 1.41e-01 |
| HNSC | cg21017775 | chr11:34513934 | CGI:chr11:34438618-34439310 | promoter | 8.63e-01 | 7.12e-01 | 2.86e+00 | 4.22e-03 | 1.24e-02 | 1.50e-01 |
| HNSC | cg11343506 | chr11:34514021 | CGI:chr11:34438618-34439310 | promoter | 8.72e-01 | 7.06e-01 | 2.79e+00 | 5.21e-03 | 1.36e-02 | 1.66e-01 |
| HNSC | cg22731981 | chr11:34514032 | CGI:chr11:34438618-34439310 | promoter | 8.49e-01 | 6.51e-01 | 2.81e+00 | 5.03e-03 | 1.34e-02 | 1.99e-01 |
| COAD | cg19656820 | chr11:34513538 | CGI:chr11:34438618-34439310 | promoter,gene body | 7.38e-01 | 9.14e-01 | -3.13e+00 | 1.75e-03 | 4.44e-03 | -1.77e-01 |
| COAD | cg24253136 | chr11:34513593 | CGI:chr11:34438618-34439310 | promoter,gene body | 7.54e-01 | 8.91e-01 | -2.19e+00 | 2.84e-02 | 3.34e-02 | -1.37e-01 |
Top |
Exon skipping events with PSI in TCGA for ELF5 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ELF5 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ELF5 |
| TFs related to ELF5. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PAAD | PRDM6 | ELF5 | 2.56e+00 | 6.25e-04 | 3.89e+00 | 9.84e-01 | Female-biased |
| PAAD | ZNF182 | ELF5 | 2.81e+00 | 8.88e-04 | 4.07e+00 | 9.87e-01 | Female-biased |
| PAAD | ZNF22 | ELF5 | 2.75e+00 | 7.18e-04 | 4.05e+00 | 9.87e-01 | Female-biased |
| PAAD | ZNF225 | ELF5 | 2.64e+00 | 6.85e-04 | 3.95e+00 | 9.85e-01 | Female-biased |
| PAAD | ZNF235 | ELF5 | 2.90e+00 | 4.82e-04 | 4.28e+00 | 9.91e-01 | Female-biased |
| PAAD | ZNF287 | ELF5 | 2.92e+00 | 5.75e-04 | 4.27e+00 | 9.91e-01 | Female-biased |
| PAAD | ZNF487 | ELF5 | 2.76e+00 | 7.44e-04 | 4.05e+00 | 9.87e-01 | Female-biased |
| PAAD | ZNF492 | ELF5 | 2.54e+00 | 8.37e-04 | 3.80e+00 | 9.81e-01 | Female-biased |
| PAAD | ZNF613 | ELF5 | 2.62e+00 | 1.10e-03 | 3.83e+00 | 9.82e-01 | Female-biased |
| PAAD | ZNF879 | ELF5 | 2.33e+00 | 1.87e-04 | 3.88e+00 | 9.84e-01 | Female-biased |
| PAAD | ZNF98 | ELF5 | 2.71e+00 | 9.46e-04 | 3.95e+00 | 9.85e-01 | Female-biased |
| ELF5 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
 |
Top |
Sex-biased RBP-ES network for ELF5 |
| RBPs related to ES in ELF5. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ELF5 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000135374 | LINC00839,hsa-mir-223,ELF5 | Tumor sex-biased ceRNA | TCGA-BRCA |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73486010 | chr11:41297643:C:T | - | 0.12173108799082 | 0.0245291369351367 | LUSC | Female-baised eQTL |
| rs73486011 | chr11:41298449:G:A | - | 0.12173108799082 | 0.0245291369351367 | LUSC | Female-baised eQTL |
| rs79345576 | chr11:36108753:G:T | - | 0.256863958131149 | 4.50069558953135e-11 | BLCA | Female-baised eQTL |
| rs12225134 | chr11:36111832:C:T | - | 0.212615683105641 | 4.08338916473624e-08 | BLCA | Female-baised eQTL |
| rs12225145 | chr11:36111989:C:A | - | 0.212615683105641 | 4.08338916473624e-08 | BLCA | Female-baised eQTL |
| rs10836494 | chr11:36112694:G:A | - | 0.193734929233887 | 6.7602716343241e-07 | BLCA | Female-baised eQTL |
| rs76274053 | chr11:36113337:A:T | - | 0.193646236470924 | 6.77421857749841e-07 | BLCA | Female-baised eQTL |
| rs118099236 | chr11:43817058:A:C | - | 0.20925707356611 | 6.75237755301161e-06 | BLCA | Female-baised eQTL |
| rs7122831 | chr11:36115253:C:T | - | 0.174581766932756 | 1.3684738555107e-05 | BLCA | Female-baised eQTL |
| rs7117426 | chr11:36113364:C:T | - | 0.159721095052128 | 3.4362572238289e-05 | BLCA | Female-baised eQTL |
| rs148646795 | chr11:43816890:G:A | - | 0.190409580467444 | 4.04046958326378e-05 | BLCA | Female-baised eQTL |
| rs7113652 | chr11:36112841:C:T | - | 0.158403144119228 | 4.73669004169334e-05 | BLCA | Female-baised eQTL |
| rs12222421 | chr11:36139629:C:A | - | 0.151464624112596 | 0.000124355033952667 | BLCA | Female-baised eQTL |
| rs55634360 | chr11:36140688:T:G | - | 0.151464624112596 | 0.000124355033952667 | BLCA | Female-baised eQTL |
| rs11033456 | chr11:36141049:T:A | - | 0.151464624112596 | 0.000124355033952667 | BLCA | Female-baised eQTL |
| rs11033457 | chr11:36141298:T:G | - | 0.151464624112596 | 0.000124355033952667 | BLCA | Female-baised eQTL |
| rs10836493 | chr11:36112447:T:G | - | 0.148435164594686 | 0.000167743278872199 | BLCA | Female-baised eQTL |
| rs74413910 | chr11:37164848:A:T | - | 0.135618256813474 | 0.000379631656541646 | BLCA | Female-baised eQTL |
| rs60444773 | chr11:36117823:A:C | - | 0.143322703699235 | 0.000476397451813931 | BLCA | Female-baised eQTL |
| rs16937949 | chr11:44430667:T:C | - | 0.151838755435176 | 0.00107239950296528 | BLCA | Female-baised eQTL |
| rs11604998 | chr11:36181044:G:A | - | 0.143390193160847 | 0.00193120620971356 | BLCA | Female-baised eQTL |
| rs12576371 | chr11:36162895:A:G | - | 0.142730543887529 | 0.00204299191589733 | BLCA | Female-baised eQTL |
| rs72937454 | chr11:36198261:T:G | - | 0.142203229230359 | 0.00220159607648131 | BLCA | Female-baised eQTL |
| rs199793219 | chr11:36144139:T:C | - | 0.1257874743189 | 0.00228741163873556 | BLCA | Female-baised eQTL |
| rs146567162 | chr11:33660374:G:A | - | 0.131939347925705 | 0.00235300650795556 | BLCA | Female-baised eQTL |
| rs72884578 | chr11:26411363:T:C | - | 0.108768557081635 | 0.00235894861608576 | BLCA | Female-baised eQTL |
| rs7929000 | chr11:36165976:C:T | - | 0.137887047654994 | 0.00242458828207285 | BLCA | Female-baised eQTL |
| rs10836628 | chr11:36870602:A:G | - | 0.126637419285667 | 0.00276768349949391 | BLCA | Female-baised eQTL |
| rs34446317 | chr11:33687653:G:A | - | 0.123588332120467 | 0.00340470100989243 | BLCA | Female-baised eQTL |
| rs16928462 | chr11:36158083:G:A | - | 0.119042765796043 | 0.00443252943363013 | BLCA | Female-baised eQTL |
| rs61885725 | chr11:39048266:C:T | - | 0.127565317213226 | 0.00658778051978515 | BLCA | Female-baised eQTL |
| rs1458388 | chr11:44427388:C:T | - | 0.130469115213926 | 0.00730516294312157 | BLCA | Female-baised eQTL |
| rs192600485 | chr11:26408260:A:G | - | 0.0901642891755223 | 0.00829788689747266 | BLCA | Female-baised eQTL |
| rs75482601 | chr11:26408981:G:C | - | 0.0901642891755223 | 0.00829788689747266 | BLCA | Female-baised eQTL |
| rs72935533 | chr11:36153047:G:C | - | 0.111904785260083 | 0.00955641939775176 | BLCA | Female-baised eQTL |
| rs3812772 | chr11:36196668:T:C | - | 0.124753207024656 | 0.00966081730555236 | BLCA | Female-baised eQTL |
| rs3812771 | chr11:36196737:T:C | - | 0.124753207024656 | 0.00966081730555236 | BLCA | Female-baised eQTL |
| rs3812769 | chr11:36196985:T:G | - | 0.124753207024656 | 0.00966081730555236 | BLCA | Female-baised eQTL |
| rs61879034 | chr11:36197346:C:T | - | 0.124753207024656 | 0.00966081730555236 | BLCA | Female-baised eQTL |
| rs16928513 | chr11:36197397:C:T | - | 0.124753207024656 | 0.00966081730555236 | BLCA | Female-baised eQTL |
| rs72937449 | chr11:36197464:G:T | - | 0.124753207024656 | 0.00966081730555236 | BLCA | Female-baised eQTL |
| rs61879035 | chr11:36197584:T:C | - | 0.124101029614373 | 0.0104700828857814 | BLCA | Female-baised eQTL |
| rs61879036 | chr11:36197661:A:T | - | 0.124101029614373 | 0.0104700828857814 | BLCA | Female-baised eQTL |
| rs75122269 | chr11:36197871:T:A | - | 0.124101029614373 | 0.0104700828857814 | BLCA | Female-baised eQTL |
| rs61879037 | chr11:36198962:G:A | - | 0.124101029614373 | 0.0104700828857814 | BLCA | Female-baised eQTL |
| rs143771996 | chr11:36199049:T:C | - | 0.124101029614373 | 0.0104700828857814 | BLCA | Female-baised eQTL |
| rs12575549 | chr11:36178292:C:T | - | 0.121662506835677 | 0.0111770228780937 | BLCA | Female-baised eQTL |
| rs10501064 | chr11:26741088:T:A | - | 0.112476485169095 | 0.0128596451727451 | BLCA | Female-baised eQTL |
| rs12576603 | chr11:36156540:C:T | - | 0.107286822177801 | 0.0137706042749987 | BLCA | Female-baised eQTL |
| rs112826783 | chr11:39049445:C:T | - | 0.11885134192671 | 0.0143436506123961 | BLCA | Female-baised eQTL |
| rs11032613 | chr11:34321238:G:C | - | 0.111680962818966 | 0.0192979576746217 | BLCA | Female-baised eQTL |
| rs11033504 | chr11:36225232:A:G | - | 0.110428000565703 | 0.021302275639332 | BLCA | Female-baised eQTL |
| rs11601619 | chr11:36200340:C:T | - | 0.11091437515141 | 0.0216426813052796 | BLCA | Female-baised eQTL |
| rs11035069 | chr11:39067684:G:A | - | 0.115762618072474 | 0.0217126873850839 | BLCA | Female-baised eQTL |
| rs11032342 | chr11:33686638:C:T | - | 0.100794301506355 | 0.0217778596263667 | BLCA | Female-baised eQTL |
| rs113464141 | chr11:39053974:C:A | - | 0.112430672246975 | 0.0229649114633371 | BLCA | Female-baised eQTL |
| rs61309051 | chr11:43218214:C:T | - | 0.10583114445196 | 0.0239860447636387 | BLCA | Female-baised eQTL |
| rs28374658 | chr11:39437735:C:T | - | 0.0910116943957051 | 0.0244221423293699 | BLCA | Female-baised eQTL |
| rs2177120 | chr11:33681873:G:A | - | 0.0980174783631667 | 0.0256845144680075 | BLCA | Female-baised eQTL |
| rs12420852 | chr11:36213474:C:T | - | 0.109319929483524 | 0.0263385127565982 | BLCA | Female-baised eQTL |
| rs72937494 | chr11:36214944:G:A | - | 0.109319929483524 | 0.0263385127565982 | BLCA | Female-baised eQTL |
| rs138937524 | chr11:39152700:G:C | - | 0.111068120727171 | 0.0268720301254659 | BLCA | Female-baised eQTL |
| rs7933303 | chr11:36167289:C:T | - | 0.104132663206841 | 0.028781703385799 | BLCA | Female-baised eQTL |
| rs7943467 | chr11:36167631:A:C | - | 0.104132663206841 | 0.028781703385799 | BLCA | Female-baised eQTL |
| rs7943612 | chr11:36167731:A:G | - | 0.104132663206841 | 0.028781703385799 | BLCA | Female-baised eQTL |
| rs61879013 | chr11:36192223:C:T | - | 0.108626756821629 | 0.0289684916030873 | BLCA | Female-baised eQTL |
| rs61886728 | chr11:39272875:T:A | - | 0.108291682760112 | 0.0294737535080571 | BLCA | Female-baised eQTL |
| rs4612777 | chr11:36166245:G:A | - | 0.106054452398179 | 0.029977243309168 | BLCA | Female-baised eQTL |
| rs7929112 | chr11:36166104:C:T | - | 0.105946702454494 | 0.0306273397244029 | BLCA | Female-baised eQTL |
| rs72935601 | chr11:36171868:A:G | - | 0.107672011974236 | 0.0322606122245653 | BLCA | Female-baised eQTL |
| rs12420381 | chr11:36172774:T:C | - | 0.107672011974236 | 0.0322606122245653 | BLCA | Female-baised eQTL |
| rs147151047 | chr11:36173441:G:T | - | 0.107672011974236 | 0.0322606122245653 | BLCA | Female-baised eQTL |
| rs61254236 | chr11:36219376:G:A | - | 0.103138572478418 | 0.0328583355934951 | BLCA | Female-baised eQTL |
| rs2068328 | chr11:39465615:T:C | - | 0.0905976191996408 | 0.034371239363142 | BLCA | Female-baised eQTL |
| rs12418840 | chr11:39168774:A:G | - | 0.106823725925928 | 0.0344161548797461 | BLCA | Female-baised eQTL |
| rs61887649 | chr11:39171680:C:T | - | 0.106823725925928 | 0.0344161548797461 | BLCA | Female-baised eQTL |
| rs139440701 | chr11:40472284:T:C | - | 0.0959590973202222 | 0.034512641248215 | BLCA | Female-baised eQTL |
| rs16932741 | chr11:39037447:C:T | - | 0.106239558145571 | 0.0360812069909817 | BLCA | Female-baised eQTL |
| rs12576661 | chr11:39110944:T:C | - | 0.106239558145571 | 0.0360812069909817 | BLCA | Female-baised eQTL |
| rs61886589 | chr11:39119752:G:A | - | 0.106239558145571 | 0.0360812069909817 | BLCA | Female-baised eQTL |
| rs61886591 | chr11:39120820:C:T | - | 0.106239558145571 | 0.0360812069909817 | BLCA | Female-baised eQTL |
| rs12574419 | chr11:36221702:G:A | - | 0.102213525503026 | 0.0367946551838272 | BLCA | Female-baised eQTL |
| rs61736869 | chr11:33668106:G:A | - | 0.0935006104574623 | 0.0369124365116128 | BLCA | Female-baised eQTL |
| rs4542380 | chr11:33675208:C:T | - | 0.0935006104574623 | 0.0369124365116128 | BLCA | Female-baised eQTL |
| rs10836098 | chr11:33675898:T:C | - | 0.0935006104574623 | 0.0369124365116128 | BLCA | Female-baised eQTL |
| rs1353466 | chr11:43221193:C:T | - | 0.100191321048882 | 0.0381263909330174 | BLCA | Female-baised eQTL |
| rs4755827 | chr11:44422825:C:T | - | 0.103712609343586 | 0.0394045810895556 | BLCA | Female-baised eQTL |
| rs11600365 | chr11:36217303:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11033501 | chr11:36217430:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs12577437 | chr11:36217558:C:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs12421400 | chr11:36217848:G:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs34892666 | chr11:36217896:G:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61881463 | chr11:36218168:T:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61881464 | chr11:36218177:A:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs72941791 | chr11:36218535:G:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61881465 | chr11:36218756:C:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs58048041 | chr11:36219292:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs59137935 | chr11:36219305:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs4468324 | chr11:36219432:C:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs4611176 | chr11:36219702:C:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs4417242 | chr11:36219720:G:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs4417243 | chr11:36219746:G:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61881468 | chr11:36220157:T:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61881469 | chr11:36220857:A:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61881470 | chr11:36220960:C:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs12574172 | chr11:36221305:C:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs12575304 | chr11:36221484:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs12575540 | chr11:36221628:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs58707777 | chr11:36221907:C:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs59051429 | chr11:36222132:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs60759289 | chr11:36222214:A:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61881476 | chr11:36222521:C:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs60544801 | chr11:36224500:A:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs58648806 | chr11:36224507:T:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11033503 | chr11:36225007:A:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11551023 | chr11:36230261:A:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs2289983 | chr11:36231292:A:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs2289981 | chr11:36231578:G:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs2289980 | chr11:36231645:C:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11603810 | chr11:36231913:G:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61881481 | chr11:36232211:A:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11606598 | chr11:36232669:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11604381 | chr11:36232909:G:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11604364 | chr11:36232958:C:G | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11604397 | chr11:36232959:G:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs112544970 | chr11:36233084:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs61627540 | chr11:36233149:G:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs1900335 | chr11:36233387:G:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs60823142 | chr11:36233418:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs59307065 | chr11:36233453:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs72939309 | chr11:36233662:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs139848377 | chr11:36233663:G:A | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs113840772 | chr11:36233709:C:T | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs112574213 | chr11:36233716:T:C | - | 0.101512724923739 | 0.0394448319930077 | BLCA | Female-baised eQTL |
| rs11037981 | chr11:44418389:A:T | - | 0.103186093024791 | 0.0402030834621311 | BLCA | Female-baised eQTL |
| rs11037987 | chr11:44423457:C:T | - | 0.103197143347322 | 0.040547269141124 | BLCA | Female-baised eQTL |
| rs61885720 | chr11:39046120:G:C | - | 0.104956789206404 | 0.0423400864904232 | BLCA | Female-baised eQTL |
| rs61879011 | chr11:36184043:G:A | - | 0.103055140909792 | 0.0428592377043117 | BLCA | Female-baised eQTL |
| rs148656856 | chr11:40472880:C:T | - | 0.0912201528789282 | 0.0434091865422623 | BLCA | Female-baised eQTL |
| rs17484505 | chr11:40481294:C:T | - | 0.0912201528789282 | 0.0434091865422623 | BLCA | Female-baised eQTL |
| rs11827314 | chr11:43263512:A:T | - | 0.0955243433403855 | 0.0450932346077474 | BLCA | Female-baised eQTL |
| rs420798 | chr11:41814626:C:T | - | 0.0889683332723295 | 0.0468423574463588 | BLCA | Female-baised eQTL |
| rs291715 | chr11:41831070:A:G | - | 0.0889683332723295 | 0.0468423574463588 | BLCA | Female-baised eQTL |
| rs144054610 | chr11:40472494:C:G | - | 0.0918816827312163 | 0.0481595647432518 | BLCA | Female-baised eQTL |
| rs11604341 | chr11:36232702:G:A | - | 0.0977757809027374 | 0.0490071063874976 | BLCA | Female-baised eQTL |
| rs111751078 | chr11:40471680:G:C | - | 0.0917999915097179 | 0.0498692432920172 | BLCA | Female-baised eQTL |
| rs10501298 | chr11:43411798:T:C | - | 0.0511399288192882 | 0.0147415229303 | LUAD | Female-baised eQTL |
| rs6485425 | chr11:43441403:C:T | - | 0.0510488848167756 | 0.0151695590918927 | LUAD | Female-baised eQTL |
| rs11823539 | chr11:43312699:A:G | - | 0.0474169030482585 | 0.0338197423867869 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs141300095 | chr11:29796027:A:G | - | 0.0941935438475466 | 0.0310988826649048 | LUAD | Male-baised eQTL |
| rs11030824 | chr11:29797947:C:A | - | 0.0941935438475466 | 0.0310988826649048 | LUAD | Male-baised eQTL |
| rs10835587 | chr11:29798157:G:C | - | 0.0941935438475466 | 0.0310988826649048 | LUAD | Male-baised eQTL |
| rs11030826 | chr11:29798966:C:T | - | 0.0941935438475466 | 0.0310988826649048 | LUAD | Male-baised eQTL |
| rs12270721 | chr11:29793586:T:G | - | 0.0923584110108652 | 0.0365387908468062 | LUAD | Male-baised eQTL |
| rs10160512 | chr11:29794624:C:A | - | 0.0923584110108652 | 0.0365387908468062 | LUAD | Male-baised eQTL |
| rs10160514 | chr11:29794661:G:A | - | 0.0923584110108652 | 0.0365387908468062 | LUAD | Male-baised eQTL |
| rs10835584 | chr11:29795459:G:A | - | 0.0923584110108652 | 0.0365387908468062 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000135374 |
| CpG Site: cg10449409 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: - | |
| Female Effect: -0.470987006904604 | |
 | Gene ID: ENSG00000135374 |
| CpG Site: cg11875459 | |
| Position to Gene: gene,promoter | |
| Male Effect: - | |
| Female Effect: -0.293622651095899 | |
 | Gene ID: ENSG00000135374 |
| CpG Site: cg10987788 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.1204546661859 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg10449409 | chr11:34511747 | gene,exon,UTR | -0.470987006904604 | 5.59901574136484e-20 | -0.5739381337168602 | 9.658625300756647e-24 | LUAD |
| cg11875459 | chr11:34513238 | gene,promoter | -0.293622651095899 | 2.05572616817446e-14 | -0.5081035824498733 | 3.8264444870910876e-18 | LUAD |
| cg10987788 | chr11:34513830 | promoter | -0.1204546661859 | 3.17417611422671e-05 | -0.4905199663637443 | 6.147027164372845e-08 | BLCA |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ELF5 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
